Welcome to our dedicated page for MEDICAL PROPERTIES TRUST SEC filings (Ticker: MPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MEDICAL PROPERTIES TRUST's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MEDICAL PROPERTIES TRUST's regulatory disclosures and financial reporting.
MEDICAL PROPERTIES TRUST INC (MPT) reported that Senior VP, Controller & CAO James Kevin Hanna purchased common stock in an open market or private transaction. He bought 2,300 shares on 2026-08-20 at $4.15 per share, bringing his direct holdings to 542,504 shares of common stock, par value $0.001.
Medical Properties Trust, Inc., through MPT Operating Partnership, L.P. and MPT Finance Corporation, entered into a material financing transaction with institutional investors, issuing $2.4 billion aggregate principal amount of new 9.25% senior secured notes due 2032 in a private placement and exchange.
The issuers intend to use the net cash proceeds to redeem in full their senior notes due 2026 and partially redeem senior notes due 2027, while the exchange component refinances approximately $1.5 billion of unsecured notes maturing between 2027 and 2031. The notes pay interest semi-annually beginning December 15, 2026 and mature on February 15, 2032, with various optional redemption features, including an equity-funded redemption of up to 40% of the notes at 109.250% of principal before August 10, 2028.
The notes are fully and unconditionally guaranteed on a joint and several basis by the company and specified subsidiaries, and are secured by first-priority liens on equity and certain real properties of first-lien guarantors, with future second-lien status tied to the revolving credit facility. The indenture includes restrictive covenants, requires total unencumbered assets of at least 150% of collective unsecured debt, and provides customary events of default and a Change of Control repurchase right at 101% of principal plus accrued interest.
Medical Properties Trust, Inc., a healthcare-focused REIT, reported for the quarter ended June 30, 2026 total revenues of $259.3 million, up from $240.4 million a year earlier, driven mainly by higher billed rent and income from leases and loans. For the first six months of 2026, revenues were $511.3 million versus $464.2 million in 2025.
Net (loss) income attributable to common stockholders was $(2.6) million for the quarter, an improvement from a $(98.4) million loss in 2025. For the six months, net income attributable to common stockholders was $30.2 million, compared with a loss of $(216.6) million, helped by lower impairment charges and smaller negative fair value adjustments.
Total assets were $14.7 billion at June 30, 2026, including a net investment in real estate assets of $10.9 billion and cash and cash equivalents of $396.6 million. Debt, net, remained high at $9.7 billion, and stockholders’ equity was $4.5 billion. The company generated $48.2 million of net cash from operating activities in the first half and paid common dividends of $0.18 per share. Medical Properties owned investments in 373 facilities across the U.S., Europe, and South America under a long-term net-lease healthcare real estate strategy.
Medical Properties Trust, Inc. reported second-quarter 2026 total revenues of $259.3 million, up from $240.4 million a year earlier, driven primarily by higher rent billed. The company recorded a net loss of $2.6 million (‑$0.01 per share), a substantial improvement from a $98.4 million loss (‑$0.16 per share) in the prior-year quarter. Normalized funds from operations (NFFO) were $92.2 million, or $0.15 per share, compared with $81.4 million, or $0.14 per share, reflecting better underlying operating performance despite ongoing impairments and high interest costs.
As of June 30 2026, Medical Properties Trust had total assets of $14.7 billion and a portfolio of 373 properties with approximately 38,000 licensed beds across the U.S. and eight other countries. Net investment in real estate assets was $10.9 billion. Debt, net totaled $9.7 billion, with adjusted net debt to annualized EBITDAre at 8.9x and an adjusted interest coverage ratio of 1.9x, highlighting a still-leveraged balance sheet.
Subsequent to quarter end, the company agreed to a major refinancing in which its operating partnership will issue $2.4 billion of new 9.25% senior secured notes due 2032 through a new-money private placement and private exchange. The transaction is expected to refinance multiple unsecured note maturities, reduce total principal debt by approximately $123 million to $9.5 billion, and leave only $1.3 billion of unsecured note maturities through 2028, materially extending the debt maturity profile.
MEDICAL PROPERTIES TRUST INC executive Charles R. Lambert, SVP of Finance and Treasurer, reported a routine tax-related share withholding. The company withheld 2,347 shares of common stock at $4.61 per share when restricted stock vested to cover tax obligations.
After this non-market transaction, Lambert directly holds 387,707 shares of common stock. The footnote clarifies this withholding does not constitute a sale in the open market.
Medical Properties Trust senior vice president and senior advisor to the CEO, Larry H. Portal, reported a routine tax-related share disposition. On the vesting of restricted stock, 4,048 shares of common stock were withheld at $4.61 per share to satisfy tax withholding obligations, as noted in the footnote that this does not constitute a sale transaction. After this tax withholding, Portal directly holds 575,028 shares of Medical Properties Trust common stock.
MEDICAL PROPERTIES TRUST INC Chairman, President & CEO Edward K. Aldag Jr. reported a compensation-related share withholding. A total of 109,433 shares of common stock were withheld at $4.61 per share upon vesting of restricted stock to satisfy tax withholding obligations, and this is explicitly described as not constituting a sale transaction. Following this tax-withholding disposition, he directly holds 6,685,775 shares of the company’s common stock.
MEDICAL PROPERTIES TRUST INC Executive Vice President & CFO R. Steven Hamner reported a routine tax-related share disposition. A total of 48,548 shares of common stock were withheld upon the vesting of restricted stock to cover tax obligations at $4.61 per share. This was not an open-market sale, and Hamner continues to hold 3,792,472 shares directly after the transaction.
MEDICAL PROPERTIES TRUST INC insider James Kevin Hanna reported a routine tax-related share disposition. Upon vesting of restricted stock, 3,295 common shares were withheld to satisfy tax withholding obligations at a reference price of $4.61 per share, which the footnote clarifies is not an open-market sale. After this non-market transaction, Hanna directly holds 540,204 common shares.
MEDICAL PROPERTIES TRUST INC senior vice president of operations Rosa Handley reported a routine tax-related share disposition. The company withheld 1,938 shares of common stock at $4.61 per share to cover tax obligations upon vesting of restricted stock, leaving her with 448,898 directly held shares. The filing clarifies this was not an open-market sale.